135 related articles for article (PubMed ID: 36122532)
1. Regulation of Derlin-1-mediated degradation of NADPH oxidase partner p22
Miyano K; Okamoto S; Kajikawa M; Kiyohara T; Kawai C; Yamauchi A; Kuribayashi F
Redox Biol; 2022 Oct; 56():102479. PubMed ID: 36122532
[TBL] [Abstract][Full Text] [Related]
2. Characterization of missense mutations in the NADPH oxidase partner p22
Kawai C; Kajikawa M; Yamauchi A; Okamoto S; Kuribayashi F; Miyano K
Microbiol Immunol; 2023 Apr; 67(4):194-200. PubMed ID: 36606663
[TBL] [Abstract][Full Text] [Related]
3. Interaction between p22
Zana M; Péterfi Z; Kovács HA; Tóth ZE; Enyedi B; Morel F; Paclet MH; Donkó Á; Morand S; Leto TL; Geiszt M
Free Radic Biol Med; 2018 Feb; 116():41-49. PubMed ID: 29278739
[TBL] [Abstract][Full Text] [Related]
4. The downregulation of NADPH oxidase Nox4 during hypoxia in hemangioendothelioma cells: a possible role of p22
Miyano K; Okamoto S; Yamauchi A; Kawai C; Kajikawa M; Kiyohara T; Itsumi M; Taura M; Kuribayashi F
Free Radic Res; 2021 Oct; 55(9-10):996-1004. PubMed ID: 35012414
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of concept using macrophages differentiated from patient-specific induced pluripotent stem cells.
Brault J; Vaganay G; Le Roy A; Lenormand JL; Cortes S; Stasia MJ
Int J Nanomedicine; 2017; 12():2161-2177. PubMed ID: 28356734
[TBL] [Abstract][Full Text] [Related]
6. Altered vascular activation due to deficiency of the NADPH oxidase component p22phox.
Wang H; Albadawi H; Siddiquee Z; Stone JM; Panchenko MP; Watkins MT; Stone JR
Cardiovasc Pathol; 2014; 23(1):35-42. PubMed ID: 24035466
[TBL] [Abstract][Full Text] [Related]
7. CYBA encoding p22(phox), the cytochrome b558 alpha polypeptide: gene structure, expression, role and physiopathology.
Stasia MJ
Gene; 2016 Jul; 586(1):27-35. PubMed ID: 27048830
[TBL] [Abstract][Full Text] [Related]
8. A Novel Interaction of Translocator Protein 18 kDa (TSPO) with NADPH Oxidase in Microglia.
Loth MK; Guariglia SR; Re DB; Perez J; de Paiva VN; Dziedzic JL; Chambers JW; Azzam DJ; Guilarte TR
Mol Neurobiol; 2020 Nov; 57(11):4467-4487. PubMed ID: 32743737
[TBL] [Abstract][Full Text] [Related]
9. Three novel mutations in CYBA among 22 Iranians with Chronic granulomatous disease.
Badalzadeh M; Tajik S; Fazlollahi MR; Houshmand M; Fattahi F; Alizadeh Z; Movahedi M; Adab Z; Khotaei GT; Hamidieh AA; Heidarnazhad H; Pourpak Z
Int J Immunogenet; 2017 Dec; 44(6):314-321. PubMed ID: 28941186
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis reveals distinct features of the Nox4-p22 phox complex.
von Löhneysen K; Noack D; Jesaitis AJ; Dinauer MC; Knaus UG
J Biol Chem; 2008 Dec; 283(50):35273-82. PubMed ID: 18849343
[TBL] [Abstract][Full Text] [Related]
11. New insights in the molecular regulation of the NADPH oxidase 2 activity: Negative modulation by Poldip2.
Bouraoui A; Louzada RA; Aimeur S; Waeytens J; Wien F; My-Chan Dang P; Bizouarn T; Dupuy C; Baciou L
Free Radic Biol Med; 2023 Apr; 199():113-125. PubMed ID: 36828293
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of p22phox on threonine 147 enhances NADPH oxidase activity by promoting p47phox binding.
Lewis EM; Sergeant S; Ledford B; Stull N; Dinauer MC; McPhail LC
J Biol Chem; 2010 Jan; 285(5):2959-67. PubMed ID: 19948736
[TBL] [Abstract][Full Text] [Related]
13. NOX4 is the main NADPH oxidase involved in the early stages of hematopoietic differentiation from human induced pluripotent stem cells.
Brault J; Vigne B; Meunier M; Beaumel S; Mollin M; Park S; Stasia MJ
Free Radic Biol Med; 2020 Jan; 146():107-118. PubMed ID: 31626946
[TBL] [Abstract][Full Text] [Related]
14. The NADPH oxidase Nox3 constitutively produces superoxide in a p22phox-dependent manner: its regulation by oxidase organizers and activators.
Ueno N; Takeya R; Miyano K; Kikuchi H; Sumimoto H
J Biol Chem; 2005 Jun; 280(24):23328-39. PubMed ID: 15824103
[TBL] [Abstract][Full Text] [Related]
15. Point mutation in the cytoplasmic domain of the neutrophil p22-phox cytochrome b subunit is associated with a nonfunctional NADPH oxidase and chronic granulomatous disease.
Dinauer MC; Pierce EA; Erickson RW; Muhlebach TJ; Messner H; Orkin SH; Seger RA; Curnutte JT
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11231-5. PubMed ID: 1763037
[TBL] [Abstract][Full Text] [Related]
16. Residual NADPH oxidase and survival in chronic granulomatous disease.
Kuhns DB; Alvord WG; Heller T; Feld JJ; Pike KM; Marciano BE; Uzel G; DeRavin SS; Priel DA; Soule BP; Zarember KA; Malech HL; Holland SM; Gallin JI
N Engl J Med; 2010 Dec; 363(27):2600-10. PubMed ID: 21190454
[TBL] [Abstract][Full Text] [Related]
17. Hematologically important mutations: The autosomal forms of chronic granulomatous disease (third update).
Roos D; van Leeuwen K; Hsu AP; Priel DL; Begtrup A; Brandon R; Rawat A; Vignesh P; Madkaikar M; Stasia MJ; Bakri FG; de Boer M; Roesler J; Köker N; Köker MY; Jakobsen M; Bustamante J; Garcia-Morato MB; Shephard JLV; Cagdas D; Tezcan I; Sherkat R; Mortaz E; Fayezi A; Shahrooei M; Wolach B; Blancas-Galicia L; Kanegane H; Kawai T; Condino-Neto A; Vihinen M; Zerbe CS; Holland SM; Malech HL; Gallin JI; Kuhns DB
Blood Cells Mol Dis; 2021 Dec; 92():102596. PubMed ID: 34547651
[TBL] [Abstract][Full Text] [Related]
18. p22phox C242T Single-Nucleotide Polymorphism Inhibits Inflammatory Oxidative Damage to Endothelial Cells and Vessels.
Meijles DN; Fan LM; Ghazaly MM; Howlin B; Krönke M; Brooks G; Li JM
Circulation; 2016 Jun; 133(24):2391-403. PubMed ID: 27162237
[TBL] [Abstract][Full Text] [Related]
19. Bioluminescence imaging of NADPH oxidase activity in different animal models.
Han W; Li H; Segal BH; Blackwell TS
J Vis Exp; 2012 Oct; (68):. PubMed ID: 23117583
[TBL] [Abstract][Full Text] [Related]
20. Developmental expression of NADPH phagocytic oxidase components in mouse embryos.
Baehner RL; Millar-Groff S; Bringas P
Pediatr Res; 1999 Aug; 46(2):152-7. PubMed ID: 10447107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
